Top Markets
Coin of the day
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
Classifica tra le azioni #41091
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
Prezzo delle azioni
$0.0202
Ultima sincronizzazione: 2024-11-19
Capitalizzazione di mercato
$44.67K
Variazione (1 giorno)
-0.49%
Variazione (1 anno)
0.00%
Paese
IL
Scambia Notable Labs, Ltd. (NTBL)

Categoria

Cronologia dei frazionamenti azionari per Notable Labs, Ltd. (NTBL)
L’azione Notable Labs, Ltd. (simbolo: NTBL) ha subito un totale di 1 frazionamenti.
L’ultimo frazionamento è avvenuto il Oct 17, 2023.
Una quota di NTBL acquistata prima di Oct 17, 2023 equivale oggi a 0.028571428571429 quote di NTBL.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
2023-10-17 1:35 x0.028571428571429 x0.028571428571429
Frazionamenti azionari di aziende simili o concorrenti
Azienda Numero di frazionamenti azionari Moltiplicatore cumulativo Il paese
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE